Delivery Order SPE2DB20D2014-SPE2DB25FB82E

Award Date 5/2/25
Potential Completion Date 5/5/25
Potential Value $56K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $3,652.65 firm-fixed price contract is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The award has an ultimate completion date of April 18, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The contract has a firm fixed price of $3,759.96 and a completion date of February 25, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as the primary vehicle for providing a comprehensive range of...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml. The award has a ceiling value of $84,034.40 and a period of performance through April 14, 2025. It is a firm fixed-price contract, with no set-aside designation. Amerisourcebergen maintains a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The delivery order is valued at $17,349.19 and has a completion date of December 5, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The contract has a ceiling value of $6,245.54 and a completion date of December 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The award has a ceiling value of $8,747.44 and an ultimate completion date of April 21, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not set aside. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The $2,031.08 firm fixed-price contract has a completion date of February 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml medication. The $44,491.13 firm fixed-price contract has an ultimate completion date of January 22, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of...
This is a $55,661.77 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides the DLA with Ozempic, a 2 mg/dose (8 mg/3 mL) 3 mL medication, with a period of performance through January 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,932.90 firm fixed-price award is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a diabetes medication. The contract has a period of performance through February 25, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB82E
    Delivery Order

This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The contract has a firm fixed price of $55,912.38 and a performance period through May 5, 2025. The award was made on May 2, 2025 and does not utilize a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is part of the company's broader support for federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 8/3/25, 12:44 AM